Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sanborn

Showing results (971-980 of 996) with videos related to

Pageof 100
Sort By:
Signal Transduction and Targeted Therapy|June 16, 2025
Garsorasib, a KRAS G12C inhibitor, with or without cetuximab, an EGFR antibody, in colorectal cancer cohorts of a phase II trial in advanced solid tumors with KRAS G12C mutationDan-Yun Ruan, Hao-Xiang Wu, Ye Xu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 15, 2022
Praluzatamab Ravtansine, a CD166-Targeting Antibody-Drug Conjugate, in Patients with Advanced Solid Tumors: An Open-Label Phase I/II TrialValentina Boni, Mary J Fidler, Hendrik-Tobias Arkenau, et al.
Cell Reports|December 3, 2014
Transcription restores DNA repair to heterochromatin, determining regional mutation rates in cancer genomesChristina L Zheng, Nicholas J Wang, Jongsuk Chung, et al.
Cell|May 1, 2018
The Energetics and Physiological Impact of Cohesin ExtrusionLaura Vian, Aleksandra Pękowska, Suhas S P Rao, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|May 18, 2025
Amivantamab in Participants with Advanced Non-small Cell Lung Cancer (NSCLC) and MET Exon 14 Skipping Mutations: Final Results From the CHRYSALIS StudyMatthew G Krebs, Byoung Chul Cho, Sandrine Hiret, et al.
NPJ Vaccines|January 11, 2022
Passive transfer of Ad26.COV2.S-elicited IgG from humans attenuates SARS-CoV-2 disease in hamstersLisa H Tostanoski, Abishek Chandrashekar, Shivani Patel, et al.
Biorxiv : the Preprint Server for Biology|May 27, 2024
Stable, chronic in-vivo recordings from a fully wireless subdural-contained 65,536-electrode brain-computer interface deviceTaesung Jung, Nanyu Zeng, Jason D Fabbri, et al.
Targeted Oncology|November 3, 2025
Amivantamab-Chemotherapy in Non-Small Cell Lung Cancer with EGFR Exon 20 Insertions: Impact of Treatment Crossover and Other Endpoints from the Phase III PAPILLON StudyRachel E Sanborn, Caicun Zhou, Ke-Jing Tang, et al.
Nature|June 23, 2021
Protective efficacy of Ad26.COV2.S against SARS-CoV-2 B.1.351 in macaquesJingyou Yu, Lisa H Tostanoski, Noe B Mercado, et al.
Stroke|January 28, 2022
Acute Ischemic Stroke, Depressed Left Ventricular Ejection Fraction, and Sinus Rhythm: Prevalence and Practice PatternsAnna D Baker, Lee H Schwamm, Danita Y Sanborn, et al.
Pageof 100

Showing results (971-980 of 996) with videos related to

Sort By:
Pageof 100
Signal Transduction and Targeted Therapy|June 16, 2025
Garsorasib, a KRAS G12C inhibitor, with or without cetuximab, an EGFR antibody, in colorectal cancer cohorts of a phase II trial in advanced solid tumors with KRAS G12C mutationDan-Yun Ruan, Hao-Xiang Wu, Ye Xu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 15, 2022
Praluzatamab Ravtansine, a CD166-Targeting Antibody-Drug Conjugate, in Patients with Advanced Solid Tumors: An Open-Label Phase I/II TrialValentina Boni, Mary J Fidler, Hendrik-Tobias Arkenau, et al.
Cell Reports|December 3, 2014
Transcription restores DNA repair to heterochromatin, determining regional mutation rates in cancer genomesChristina L Zheng, Nicholas J Wang, Jongsuk Chung, et al.
Cell|May 1, 2018
The Energetics and Physiological Impact of Cohesin ExtrusionLaura Vian, Aleksandra Pękowska, Suhas S P Rao, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|May 18, 2025
Amivantamab in Participants with Advanced Non-small Cell Lung Cancer (NSCLC) and MET Exon 14 Skipping Mutations: Final Results From the CHRYSALIS StudyMatthew G Krebs, Byoung Chul Cho, Sandrine Hiret, et al.
NPJ Vaccines|January 11, 2022
Passive transfer of Ad26.COV2.S-elicited IgG from humans attenuates SARS-CoV-2 disease in hamstersLisa H Tostanoski, Abishek Chandrashekar, Shivani Patel, et al.
Biorxiv : the Preprint Server for Biology|May 27, 2024
Stable, chronic in-vivo recordings from a fully wireless subdural-contained 65,536-electrode brain-computer interface deviceTaesung Jung, Nanyu Zeng, Jason D Fabbri, et al.
Targeted Oncology|November 3, 2025
Amivantamab-Chemotherapy in Non-Small Cell Lung Cancer with EGFR Exon 20 Insertions: Impact of Treatment Crossover and Other Endpoints from the Phase III PAPILLON StudyRachel E Sanborn, Caicun Zhou, Ke-Jing Tang, et al.
Nature|June 23, 2021
Protective efficacy of Ad26.COV2.S against SARS-CoV-2 B.1.351 in macaquesJingyou Yu, Lisa H Tostanoski, Noe B Mercado, et al.
Stroke|January 28, 2022
Acute Ischemic Stroke, Depressed Left Ventricular Ejection Fraction, and Sinus Rhythm: Prevalence and Practice PatternsAnna D Baker, Lee H Schwamm, Danita Y Sanborn, et al.
Pageof 100